Results 201 to 210 of about 143,935 (260)

Loss of DNA methylation is not associated with venetoclax–hypomethylating agents synergy in acute myeloid leukaemia cells

open access: yes
British Journal of Haematology, EarlyView.
Aida Selimović‐Pašić   +6 more
wiley   +1 more source

Nicotinic Acid Restriction Enhances the Therapeutic Benefit of NAMPT Inhibition in Small‐Cell Lung Cancer Models

open access: yesCancer Science, EarlyView.
Dietary NA restriction converts the effect of NAMPT inhibition from cytostatic to cytotoxic in SCLC in vivo. ABSTRACT Small‐cell lung cancer (SCLC) is an aggressive malignancy with limited therapeutic options. We previously showed that nicotinic acid riboside (NAR) sustains NAD biosynthesis in vivo and compensates for NAMPT inhibition in SCLC models ...
Kyoji Tsurumi   +12 more
wiley   +1 more source

Prussian Blue Nanozyme Potentiates Venetoclax Efficacy in Acute Myeloid Leukemia by Inducing a More Mature Phenotype. [PDF]

open access: yesInt J Nanomedicine
Yang F   +10 more
europepmc   +1 more source

Integrating ex vivo drug sensitivity and genetic mutation analysis improves prediction of chemotherapy response in acute myeloid leukemia. [PDF]

open access: yesFunct Integr Genomics
Li W   +13 more
europepmc   +1 more source

Total body irradiation is associated with increased burden of cerebral microbleeds in haematopoietic stem cell transplant recipients

open access: yes
British Journal of Haematology, EarlyView.
Jure Hederih   +13 more
wiley   +1 more source

A 3‐year‐old girl with a left optic nerve tumor

open access: yes
Brain Pathology, EarlyView.
Samuel López Muñoz   +10 more
wiley   +1 more source

P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML. [PDF]

open access: yesSci Adv
Goetz ML   +8 more
europepmc   +1 more source

Very Late Extramedullary Relapse of Acute Myeloid Leukemia 13 Years After Allogeneic Transplant: A Case Report. [PDF]

open access: yesCase Rep Hematol
von Aarburg Y   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy